1. Taiwan, Province of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
St.Shine Optical Co.,Ltd.

St.Shine Optical Co.,Ltd.

1565.TWO
St.Shine Optical Co.,Ltd.TW flagTaipei Exchange
97.00
TWD
+0.20
- -
4.89BMarket Cap
St.Shine Optical Co.,Ltd.
1565.TWO
(Taipei Exchange)

Recent

price

97.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
61.47
68.6
82.68
103.58
107.33
116.24
128.1
127.3
132.42
125.88
99.3
107.14
99.24
87.15
90.25
81.7
91.8
Revenue per Share
17.3
21.16
23.96
31.7
31.2
28.88
35.26
31.52
33.07
25.53
14.78
18.8
20.21
10.83
14.82
9.03
12.41
Basic EPS, GAAP
3.8
17.11
11.71
22.94
27.3
38.88
46.75
3.4
23.84
21.57
15.96
22.99
22.85
16.14
17.07
10.08
14.02
Free Cash Flow per Basic Share
10.5
14.5
15.5
17.5
22.5
23.85
23.5
27
25
26.5
18
12
15
13.5
7
9.5
- -
Dividend per Share
33.09
37.11
43.23
66.72
60.72
62.59
71.34
72.21
77.19
73.12
67.9
73.2
76.93
72.42
79.69
78.05
72.74
Book Value per Share
48.92
54.65
62.89
77.05
86.01
91.11
102.69
106.94
115.06
114.23
111.53
118.38
124.27
121.63
130
129.92
124.69
Tangible Book Value per Share
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
50
Basic Weighted Avg Shares
3,099
3,459
4,169
5,222
5,411
5,860
6,458
6,418
6,676
6,347
5,007
5,402
5,003
4,394
4,550
4,117
4,622
Sales/Revenue/Turnover
37.84
34.26
33.54
33.96
33.29
28.43
34.82
32.27
30.42
26.18
20.08
22.4
21.36
13.67
17.57
13.92
18.54
Operating Margin (%)
132
190
210
253
339
321
278
251
277
359
330
320
329
322
281
241
255
Depreciation Expense
872
1,067
1,208
1,598
1,573
1,456
1,778
1,589
1,668
1,287
745
948
1,019
546
747
455
625
Net Income, GAAP
17.56
12.3
12.22
13.29
15.47
15.23
17.43
19.13
20.31
20.28
20.84
17.85
20.45
19.58
20.74
21.16
21.41
Effective Tax Rate (%)
28.14
30.84
28.97
30.6
29.07
24.85
27.52
24.76
24.98
20.28
14.88
17.55
20.37
12.43
16.42
11.05
13.51
Profit Margin (%)
1,341
1,499
1,748
1,767
2,153
2,596
3,293
2,467
2,400
2,281
2,154
2,438
2,780
2,633
3,031
3,026
2,754
Working Capital
371
307
930
802
680
594
507
1,025
870
933
749
546
440
317
255
157
214
LT Debt
2,467
2,756
3,171
3,885
4,337
4,594
5,177
5,392
5,806
5,763
5,626
5,971
6,268
6,136
6,558
6,551
6,281
Total Equity
34.3
33.01
32.3
32.56
29.14
25.95
31.82
24.89
22.07
18.19
11.05
13.42
11.28
6.71
8.95
6.35
9.82
Return on Invested Capital (%)
45.54
48.12
43.86
42.05
38.18
37.33
43.29
32.94
31.78
25.52
15.42
19.34
20.67
12.1
17
10.33
15.04
Return on Capital (%)
57.09
60.29
59.64
57.67
48.97
46.84
52.66
43.92
44.28
33.97
20.96
26.65
26.93
14.5
19.49
11.45
17.28
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
289
304
291
LT Borrowings
186
160
134
LT Finance Leases
69
86
79
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
50
50
50
Market Capitalization
9,950
9,396
7,805

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
4,277
4,280
4,210
Cash, Cash Equivalents & STI
2,376
2,436
2,415
Accounts Receivable, Net
725
693
638
Inventories
1,086
1,074
1,068
Total Current Liabilities
1,246
1,543
1,456
Payables & Accruals
- -
- -
- -
ST Debt
289
304
291
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.72%
3.15%
-0.11%
Free Cash Flow
47.29%
-4.22%
-40.98%
Net Income, GAAP
-6.24%
-2.79%
-39.11%
Sales/Revenue/Turnover
-3.01%
-3.53%
-9.52%
Total Cash Common Dividend
-5.08%
-6.15%
35.71%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
1,131
1,074
1,054
1,134
4,394
2024
1,100
996
1,224
1,230
4,550
2025
1,111
1,058
942
- -
4,117

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
3.23
2.74
2.73
- -
10.83
2024
3.77
2.67
3.9
- -
14.82
2025
3.43
0.57
- -
- -
9.03

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
13.5
2024
- -
- -
- -
- -
7
2025
- -
- -
- -
- -
9.5
Similar Companies
Well Lead Medical Co., Ltd. (603309.SS)
Hamilton Thorne Ltd. (HTL.TO)
HOYA Corporation (HOCPY)
Standard Dental Labs Inc. (TUTH)
NEXGEL, Inc. (NXGL)
Predictive Oncology Inc. (POAI)
Business
St.Shine Optical Co., Ltd. (1565.TWO) manufactures, sells, and trades contact lenses, optical lenses, and related products primarily for vision correction including myopia, hyperopia, and astigmatism; its core offerings encompass daily disposable soft contact lenses, frequent replacement lenses, color lenses, silicone hydrogel soft contact lenses, toric lenses, aberration control lenses, cast-molded soft contact lenses, and conventional lathe-cut lenses such as rigid gas permeable and soft variants, marketed under the Ticon brand while providing OEM, ODM, private label services, and consulting. Founded in 1981 as First Optical Co., Ltd. and rebranded in 1986, the company is headquartered in New Taipei City, Taiwan, with production facilities in Xizhi District, Keelung, and additional plants including Kang Ning, Asia-Pacific, Taiwan Science, Wudu, and Xike; it operates across Asia, Europe, North America, the Middle East, Japan, mainland China, Southeast Asia, and South America, holding certifications such as ISO 13485:2016, MDSAP, TFDA QMS, CE Marking, U.S. FDA 510(K), and approvals from regulatory bodies in Thailand, Vietnam, Indonesia, Malaysia, Australia, Singapore, Philippines, and Korea. Recent developments include new equity-method investments in affiliated companies during 2024, board changes with newly elected directors and independent directors effective June 2024, acquisition of property, plant, and equipment for NT$92.9 million alongside intangible assets, expansion of right-of-use assets through long-term factory leases, and sustained revenue growth to NT$4.55 billion in 2024 from strong operating performance.